FDA Approves First Fibromyalgia Treatment in 15 Years

AUGUST 21, 2025

Can Manufacturer and Payor Incentives Align?

AUGUST 21, 2025

Partnership on SDOH Bolsters Rheumatoid Arthritis Outcomes

AUGUST 20, 2025

Email This Article

POSTED: MARCH 25, 2025

Real-World Data Show Continued Virologic Suppression With Cabenuva

At CROI 2025, new research has shown high rates of continued virologic suppression with cabotegravir-rilpivirine (Cabenuva, ViiV Healthcare).
A link to this article will be included in this email.

Recipient's Email Address:

Enter email addresses separated by commas if sending to more than one person. (200 characters max)

Your Name:

Your Email Address:

Send me a copy

Personal Message: (Optional)

These email addresses will only be used to send out this message.

Please wait..

Videos

MARCH 25, 2025

CROI 2025

Real-World Data Show Continued Virologic Suppression With Cabenuva

To read the full story, Log in or Sign up for a Free Account

Check out our new Clinical tab!

We've added an exciting new feature to our website. Click on "Clinical" in the navbar to explore!

The following result is from the NPI Registry Public Search database. You can click on the NPI number to view detailed information and verify its accuracy. If your NPI is not found in this search, you can try searching again using the form below. If you have difficulty finding your NPI number please contact us at web@mcmahonmed.com

First Name

Last Name

Organization/Institution

State

NPI	Name	Organization/ Institution	State	Zip Code	Taxonomy	Credential	Select